How to better stratify the risk of differentiated thyroid carcinomas: the key role of radioactive iodine therapy, age, and gender

被引：0
|
作者：
Arnoldo Piccardo
Giacomo Siri
Stefano Raffa
Marco Castellana
Luca Foppiani
Gianluca Bottoni
Martina Ugolini
Angelina Cistaro
Ugo Catrambone
Vania Altrinetti
Michela Massollo
Anselmo Arlandini
Luca Giovanella
Manlio Cabria
Pierpaolo Trimboli
机构：
[1] E.O. “Ospedali Galliera”,Department of Nuclear Medicine
[2] University of Genoa,Department of Mathematics
[3] Galliera Hospital,Scientific Directorate
[4] IRCCS Ospedale Policlinico San Martino,Nuclear Medicine Unit
[5] National Institute of Gastroenterology “Saverio De Bellis”,Department of Internal Medicine
[6] E.O. “Ospedali Galliera”,Department of Surgery
[7] Galliera Hospital,Clinic for Nuclear Medicine and Competence Center for Thyroid Diseases, Imaging Institute of Southern Switzerland
[8] Ente Ospedaliero Cantonale,Clinic for Nuclear Medicine
[9] University Hospital and University of Zurich,Faculty of Biomedical Sciences
[10] Università della Svizzera Italiana (USI),undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2021年 / 48卷
关键词：
DTC; Risk stratification; RAI; Elderly; Gender;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：822 / 830
页数：8
相关论文
共 50 条
  • [1] How to better stratify the risk of differentiated thyroid carcinomas: the key role of radioactive iodine therapy, age, and gender
    Piccardo, Arnoldo
    Siri, Giacomo
    Raffa, Stefano
    Castellana, Marco
    Foppiani, Luca
    Bottoni, Gianluca
    Ugolini, Martina
    Cistaro, Angelina
    Catrambone, Ugo
    Altrinetti, Vania
    Massollo, Michela
    Arlandini, Anselmo
    Giovanella, Luca
    Cabria, Manlio
    Trimboli, Pierpaolo
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (03) : 822 - 830
  • [2] Radioactive iodine therapy in poorly differentiated thyroid cancer
    R Michael Tuttle
    Ravinder K Grewal
    Steve M Larson
    Nature Clinical Practice Oncology, 2007, 4 : 665 - 668
  • [3] Radioactive iodine therapy in poorly differentiated thyroid cancer
    Tuttle, R. Michael
    Grewal, Ravinder K.
    Larson, Steve M.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (11): : 665 - 668
  • [4] Risk of second primary malignancy in differentiated thyroid carcinoma treated with radioactive iodine therapy
    Lang, Brian Hung-Hin
    Wong, Irene Oi Ling
    Wong, Kai Pun
    Cowling, Benjamin J.
    Wan, Koon-Yat
    SURGERY, 2012, 151 (06) : 844 - 850
  • [5] Radioactive iodine (RAI) therapy for metastatic differentiated thyroid cancer
    Verburg, Frederik A.
    Haenscheid, Heribert
    Luster, Markus
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 31 (03) : 279 - 290
  • [6] Radioactive Iodine Therapy in Differentiated Thyroid Cancer: 2020 Update
    Ciarallo, Anthony
    Rivera, Juan
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2020, 215 (02) : 285 - 291
  • [7] Outcome of pregnancy after radioactive iodine treatment for well differentiated thyroid carcinomas
    Lin, JD
    Wang, HS
    Weng, HF
    Kao, PF
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1998, 21 (10) : 662 - 667
  • [8] Outcome of pregnancy after radioactive iodine treatment for well differentiated thyroid carcinomas
    Jen-Der Lin
    H. S. Wang
    H. F. Weng
    P. F. Kao
    Journal of Endocrinological Investigation, 1998, 21 : 662 - 667
  • [9] The role of radioactive iodine in the treatment of advanced differentiated thyroid carcinoma
    Pelikan, DMV
    Lion, HL
    Hermans, J
    Goslings, BM
    CLINICAL ENDOCRINOLOGY, 1997, 47 (06) : 713 - 720
  • [10] Risk Factors for Indeterminate Response After Radioactive Iodine Therapy in Patients With Differentiated Thyroid Cancer
    Jeong, Eugene
    Yoon, Joon-Kee
    Lee, Su Jin
    Soh, Euy Young
    Lee, Jeonghun
    An, Young-Sil
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (09) : 714 - 718
12345